Vivos Therapeutics's total assets is $25M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Vivos Therapeutics (VVOS) currently reports a total assets of $25M as of March 2026. That compares with $11M in the prior-year period — up 122.0% year over year. Use the charts on this page to explore Vivos Therapeutics's total assets history and peer comparisons.
Vivos Therapeutics's total assets increased from $11M to $25M — a 122.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Vivos Therapeutics reported $25M in total assets as of March 2026. That compares with $11M in the prior-year period — up 122.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $25M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vivos Therapeutics, and consider following VVOS for alerts when major investors trade the stock.
Vivos Therapeutics is classified in the Healthcare sector. On total assets, it currently shows $25M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VVOS with unrelated industries.